Skip to Main Content

Author Details

Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
2009
86
32
PMIDPaper TitleJournal TitlePublished Year
35306541Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men.Prostate Cancer Prostatic Dis2023
37550448Genomic Characterization of Aggressive Breast Cancer in Younger Women.Ann Surg Oncol2023
37003878Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors.Urol Oncol2023
37262399Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate Cancer.JCO Oncol Pract2023
36522269Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent Outcome.Clin Genitourin Cancer2023
36400666Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis.Urol Oncol2023
35230441Racial Differences in Genomic Profiles of Breast Cancer.JAMA Netw Open2022
35509021Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer.Clin Epigenetics2022
36187555Genomic alterations predictive of poor clinical outcomes in pan-cancer.Oncotarget2022
35245846DNA repair and immune checkpoint blockade response.Cancer Genet2022
35022600Clinicogenomic characterization of prostate cancer liver metastases.Prostate Cancer Prostatic Dis2022
32896505Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer.Clin Genitourin Cancer2021
33840559Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer.Eur Urol2021
33864110Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation.J Cancer Res Clin Oncol2021
33750906Correlative analysis between two commercially available post-prostatectomy genomic tests.Prostate Cancer Prostatic Dis2021
33632928Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection.Clin Cancer Res2021
34934057The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer.Nat Commun2021
34551377Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE).Cancer Genet2021
34131070The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics.Mol Cancer Res2021
34083737Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.Commun Biol2021
33452241The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair.Nat Commun2021
32461072Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer.Eur Urol2020
34085047A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance.Nat Cancer2020
31905251Genomic and clinical characterization of stromal infiltration markers in prostate cancer.Cancer2020
33144576Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.Nat Commun2020
33299986Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes.Eur Urol Open Sci2020
32905685Racial Differences in Genomic Profiling of Prostate Cancer.N Engl J Med2020
32585335Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine Tumors.Int J Radiat Oncol Biol Phys2020
30367117Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.Prostate Cancer Prostatic Dis2019
32721098Epigenetic analysis identifies factors driving racial disparity in prostate cancer.Cancer Rep (Hoboken)2019
31515456Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer.Clin Cancer Res2019
30952638Molecular Characterization of Neuroendocrine-like Bladder Cancer.Clin Cancer Res2019
31125117Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.Int J Cancer2019
31010837Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types.Clin Cancer Res2019
31164324Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications.Eur Urol Oncol2019
30683576Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Scores.Eur Urol2019
29478736Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.Eur Urol2018
29853306The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer.Eur Urol2018
29729848Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.EBioMedicine2018
29511883Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer.J Cancer Res Clin Oncol2018
29761525ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.Prostate2018
29760221Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy.Clin Cancer Res2018
29757368The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.Gigascience2018
27460352Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer.Eur Urol2017
28140459Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes.Cancer2017
28494073Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.JAMA Oncol2017
28341589Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.J Mol Diagn2017
29132337Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma.BMC Cancer2017
28881605Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.Oncotarget2017
28591577Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.Cell Rep2017
  • 1 - 50 of 86

Recommended Authors

Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 24
Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 9
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 20
Takafumi N Yamaguchi
University of California los angeles
Career Start Year 2015
Number of shared co-authors 23
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 15
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 21
Ren?? B??ttcher
Universitat Pompeu Fabra
Career Start Year 2012
Number of shared co-authors 5
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 42
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 25
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 26
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 19
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 22
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 14
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 8
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 36
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 15
Adam Foye
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 32
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 12
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 31
Wassim Abida
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 44
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2001
Number of shared co-authors 48
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 17
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 10
Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 50
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 29
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 35
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 5
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 38
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year 1990
Number of shared co-authors 21
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 26

Collaborators

Elai Davicioni
Veracyte Inc.
Co-authored papers 50
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 30
Nicholas Erho
GenomeDx Biosciences Inc.
Co-authored papers 29
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 26
Brandon A Mahal
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 24
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 22
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 21
Ashley E Ross
Northwestern University
Co-authored papers 19
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers 18
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 14
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 14
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Co-authored papers 13
Mandeep Takhar
GenomeDx Biosciences Inc.
Co-authored papers 11
Yang Liu
Veracyte inc.
Co-authored papers 10
Eric A Klein
Cleveland Clinic
Co-authored papers 9
Lucia L Lam
School of Clinical Medicine, University of Hong Kong, Queen Mary Hospital
Co-authored papers 7
Stephen J Freedland
Cedars-Sinai Medical Center
Co-authored papers 7
Nishwant Swami
University of Massachusetts Medical School, Harvard TH Chan School of Public Health
Co-authored papers 7
Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 6
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 6
Amar U Kishan
University of California los angeles
Co-authored papers 5
Bruce J Trock
Johns Hopkins University School of Medicine
Co-authored papers 4
Alan Pollack
University of Miami Miller School of Medicine
Co-authored papers 4
Edward Christopher Dee
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Colin C Collins
University of British Columbia
Co-authored papers 4
Mark A Rubin
University of Bern
Co-authored papers 4
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 4
Yuzhuo Wang
University of British Columbia
Co-authored papers 3
Varune R Ramnarine
University of British Columbia
Co-authored papers 3
Martin Sj??str??m
University of California-San Francisco
Co-authored papers 3
Release 1.2